Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Lupin Receives U.S. FDA Approval for Phytonadione Injectable Emulsion, USP
08 Oct 2026
PR Newswire Association LLC.
Apollo Clinical Research Conclave 2026 Explores the Future of Integrated Healthcare Innovation
07 Oct 2026
PR Newswire Association LLC.
ADAMA Launches Botanical Fungicide Actavan® in Australia and New Zealand
01 Oct 2026
PR Newswire Association LLC.
Sun Pharma Launches (C)Taro-Methylphenidate ER, the First and Only Bioequivalent to Concerta® with an Osmotic Delivery System
24 Sep 2026
PR Newswire Association LLC.
Clean Bio Korea to Showcase Indonesia-Validated Air-Fit at Hospital Expo 2026
21 Sep 2026
PR Newswire Association LLC.
Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore
31 Aug 2026
PR Newswire Association LLC.
Apollo Hospitals launches 'Always Open, Always Here', a global first in healthcare from India
20 Aug 2026
PR Newswire Association LLC.
HCG begins patient treatment on Karnataka's first Elekta Unity MR-Linac, bringing MR-guided adaptive radiation therapy to the state
18 Aug 2026
PR Newswire Association LLC.
NUH RECOGNISED AMONG WORLD'S GREENEST HOSPITALS; ONLY SINGAPORE HOSPITAL AWARDED HIGHEST DISTINCTION
11 Aug 2026
PR Newswire Association LLC.
Experts at Apollo Hospital, Bilaspur, Remove Esophagus Cancer, Create A New Food Passage Using Stomach
06 Aug 2026
PR Newswire Association LLC.
Cipla Health's new 'W.H.O. hai toh woh ORS hai' campaign highlights the importance of knowing the correct ORS
30 Jul 2026
PR Newswire Association LLC.
Apollo Hospitals Pune Performs Its First Robotic-Assisted Coronary Artery Bypass Surgery
29 Jul 2026
PR Newswire Association LLC.
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
29 Jul 2026
PR Newswire Association LLC.
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
28 Jul 2026
GlobeNewswire
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
31 Jul 2026
GlobeNewswire
Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed
21 Jul 2026
GlobeNewswire
Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN
17 Jul 2026
GlobeNewswire
Organic & Natural Health Association and India's SHEFEXIL Establish Strategic Partnership to Strengthen U.S.-India Supply Chain
14 Jul 2026
GlobeNewswire
Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients
06 Jul 2026
GlobeNewswire
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
02 Jul 2026
GlobeNewswire
Travel Fatigue Treatments Gain Traction as Summer Travel Increases, Says Prana IV Therapy
30 Jun 2026
GlobeNewswire
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
12 Jun 2026
GlobeNewswire
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
11 Jun 2026
GlobeNewswire
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
08 Jun 2026
GlobeNewswire
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
04 Jun 2026
GlobeNewswire
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
03 Jun 2026
GlobeNewswire
Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML
01 Jun 2026
Upcoming Events All Events
- October 2026
- Yokohama: BioJapan
- Queensland: AusBiotech Invest
- Queensland: AusBiotech International Conference